Zeynep İmAmoğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zeynep İmAmoğlu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Özdemir
Ondokuz Mayıs University
2 shared publications - Abdülcemal Gürpınar
Department of Ophthalmology, Ordu State Hospital, Ordu, Türkiye
1 shared publication - Begüm Kalyoncu
Department of Ophthalmology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
1 shared publication Canan Seren
Department of Neonatology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
1 shared publication- İnCi Güngör
Ondokuz Mayıs University
1 shared publication - Mertcan Esenkaya
Ondokuz Mayıs University
1 shared publication
Latest Publications
- Open Access
- 4 October 2026
- Published by Springer Nature in BMC Ophthalmology
Association of the C-reactive protein-to-albumin ratio with treatment-requiring retinopathy of prematurity in premature infants
- 4 October 2026
- Published by Springer Nature in BMC Ophthalmology
Open AccessAssociation of the C-reactive protein-to-albumin ratio with treatment-requiring retinopathy of prematurity in premature infants
- 31 March 2026
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 109 (7) , 1-9
Quantitative analysis of macular and peripapillary microvasculature in non-arteritic anterior ischaemic optic neuropathy
Non-arteritic anterior ischaemic optic neuropathy is a major cause of optic nerve dysfunction in older adults. Understanding its structural and microvascular consequences is essential for identifying disease susceptibility and guiding clinical monitoring. Non-arteritic anterior ischaemic optic neuropathy results from impaired perfusion of the optic nerve head, leading to permanent structural and vascular injury. Although clinically affected eyes show marked damage, fellow eyes may also demonstrate anatomical crowding and reduced vascular supply. This retrospective observational study included eyes with chronic non-arteritic anterior ischaemic optic neuropathy, their unaffected fellow eyes, and age- and sex-matched controls. Structural parameters, including peripapillary retinal nerve fibre layer thickness, ganglion cell complex thickness, and optic disc morphology, were assessed using swept-source optical coherence tomography. Macular vessel density, radial peripapillary capillary plexus density, and inside-disc vessel density were evaluated using optical coherence tomography angiography. Eyes with chronic non-arteritic anterior ischaemic optic neuropathy showed marked neuroaxonal loss, with significantly reduced inferior pRNFL thickness (78.15 ± 29.42 µm vs 131.64 ± 16.44 µm in controls; p < 0.001) and foveal GCC thickness (31.0 µm vs 47.0 µm; p < 0.001). The vertical cup-to-disc ratio was significantly lower in both affected and fellow eyes compared to controls (0.29 and 0.25 vs 0.45; p < 0.001). Macular parafoveal vessel density and radial peripapillary capillary plexus density were significantly reduced in affected eyes (e.g. superior SCP 41.44 ± 3.38% vs 46.61 ± 3.44%; RPC superior 38.14 ± 4.94% vs 50.82 ± 2.54%; both p < 0.001), while fellow eyes demonstrated intermediate structural and vascular values. Chronic non-arteritic anterior ischaemic optic neuropathy is associated with persistent neuroaxonal thinning and microvascular reduction. Fellow eyes exhibit a disc-at-risk configuration and subtle peripapillary perfusion changes, suggesting bilateral anatomical susceptibility. Optical coherence tomography and optical coherence tomography angiography may help identify subclinical vulnerability and support longitudinal monitoring.
- 31 March 2026
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 109 (7) , 1-9
Quantitative analysis of macular and peripapillary microvasculature in non-arteritic anterior ischaemic optic neuropathy
Non-arteritic anterior ischaemic optic neuropathy is a major cause of optic nerve dysfunction in older adults. Understanding its structural and microvascular consequences is essential for identifying disease susceptibility and guiding clinical monitoring. Non-arteritic anterior ischaemic optic neuropathy results from impaired perfusion of the optic nerve head, leading to permanent structural and vascular injury. Although clinically affected eyes show marked damage, fellow eyes may also demonstrate anatomical crowding and reduced vascular supply. This retrospective observational study included eyes with chronic non-arteritic anterior ischaemic optic neuropathy, their unaffected fellow eyes, and age- and sex-matched controls. Structural parameters, including peripapillary retinal nerve fibre layer thickness, ganglion cell complex thickness, and optic disc morphology, were assessed using swept-source optical coherence tomography. Macular vessel density, radial peripapillary capillary plexus density, and inside-disc vessel density were evaluated using optical coherence tomography angiography. Eyes with chronic non-arteritic anterior ischaemic optic neuropathy showed marked neuroaxonal loss, with significantly reduced inferior pRNFL thickness (78.15 ± 29.42 µm vs 131.64 ± 16.44 µm in controls; p < 0.001) and foveal GCC thickness (31.0 µm vs 47.0 µm; p < 0.001). The vertical cup-to-disc ratio was significantly lower in both affected and fellow eyes compared to controls (0.29 and 0.25 vs 0.45; p < 0.001). Macular parafoveal vessel density and radial peripapillary capillary plexus density were significantly reduced in affected eyes (e.g. superior SCP 41.44 ± 3.38% vs 46.61 ± 3.44%; RPC superior 38.14 ± 4.94% vs 50.82 ± 2.54%; both p < 0.001), while fellow eyes demonstrated intermediate structural and vascular values. Chronic non-arteritic anterior ischaemic optic neuropathy is associated with persistent neuroaxonal thinning and microvascular reduction. Fellow eyes exhibit a disc-at-risk configuration and subtle peripapillary perfusion changes, suggesting bilateral anatomical susceptibility. Optical coherence tomography and optical coherence tomography angiography may help identify subclinical vulnerability and support longitudinal monitoring.